Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: All you need to know about Johnson & Johnson’s Q1 2023 earnings results
Johnson & Johnson (NYSE: JNJ) reported its first quarter 2023 earnings results today.
Reported sales increased 5.6% year-over-year to $24.7 billion.
On a GAAP basis, the company reported net loss of $68 million, or $0.03 per share, compared to net income of $5.1 billion, or $1.93 per share, last year. Adjusted EPS was $2.68.
Both revenue and adjusted EPS beat expectations.
For the full year of 2023, the company expects adjusted operational sales to grow 4.5-5.5% year-over-year.
Prior performance
Most Popular
Broadcom (AVGO) thrives on growing AI business. Is the stock a buy?
Broadcom, Inc. (NASDAQ: AVGO), a leading provider of semiconductor solutions for wired and wireless communications, recently impressed the market with upbeat financial outlook highlighting strong prospects for its AI business
After a weak first half, will NIKE (NKE) hit the recovery path this year?
After a prolonged slowdown, NIKE, Inc. (NYSE: NKE) is working on a turnaround plan to regain the brand’s strength. In recent years, the sneaker giant’s overall performance has not been
Lennar (LEN): Even the best-laid plans can go wrong
Shares of Lennar Corporation (NYSE: LEN) stayed green on Monday. The stock has dropped 25% over the past three months. The homebuilder delivered underwhelming results for the fourth quarter of
